- Home
- SCLX vs SMSI Comparison
SCLX vs SMSI Comparison
Compare SCLX & SMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLX
- SMSI
- Stock Information
- Founded
- SCLX 2011
- SMSI 1982
- Country
- SCLX United States
- SMSI United States
- Employees
- SCLX N/A
- SMSI N/A
- Industry
- SCLX Biotechnology: Pharmaceutical Preparations
- SMSI Computer Software: Prepackaged Software
- Sector
- SCLX Health Care
- SMSI Technology
- Exchange
- SCLX Nasdaq
- SMSI Nasdaq
- Market Cap
- SCLX 28.4M
- SMSI 24.7M
- IPO Year
- SCLX N/A
- SMSI 1995
- Fundamental
- Price
- SCLX $4.78
- SMSI $0.90
- Analyst Decision
- SCLX Strong Buy
- SMSI Strong Buy
- Analyst Count
- SCLX 4
- SMSI 1
- Target Price
- SCLX $396.67
- SMSI $5.00
- AVG Volume (30 Days)
- SCLX 206.3K
- SMSI 144.0K
- Earning Date
- SCLX 05-23-2025
- SMSI 05-07-2025
- Dividend Yield
- SCLX N/A
- SMSI N/A
- EPS Growth
- SCLX N/A
- SMSI N/A
- EPS
- SCLX N/A
- SMSI N/A
- Revenue
- SCLX $56,590,000.00
- SMSI $19,378,000.00
- Revenue This Year
- SCLX $115.30
- SMSI $36.40
- Revenue Next Year
- SCLX $73.33
- SMSI $46.07
- P/E Ratio
- SCLX N/A
- SMSI N/A
- Revenue Growth
- SCLX 21.07
- SMSI N/A
- 52 Week Low
- SCLX $3.60
- SMSI $0.52
- 52 Week High
- SCLX $80.50
- SMSI $2.90
- Technical
- Relative Strength Index (RSI)
- SCLX 39.15
- SMSI 46.04
- Support Level
- SCLX $3.92
- SMSI $0.91
- Resistance Level
- SCLX $6.13
- SMSI $1.09
- Average True Range (ATR)
- SCLX 0.69
- SMSI 0.08
- MACD
- SCLX 0.13
- SMSI -0.01
- Stochastic Oscillator
- SCLX 32.56
- SMSI 1.82
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About SMSI Smith Micro Software Inc.
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. It offers multi-platform, modular solutions such as SafePath; CommSuite; and ViewSpot. The company's only reportable segment is Wireless. Its Wireless segment sells to large wireless carriers, cable operators, and OEMs.